Plk Ideal Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 16-11-2024
- Paid Up Capital ₹ 0.60 M
as on 16-11-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 69.05%
(FY 2023)
- Ebitda 34.52%
(FY 2023)
- Net Worth -5.04%
(FY 2023)
- Total Assets -0.59%
(FY 2023)
About Plk Ideal Medical Systems
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹2.00 M.
Yogesh Lahoti, Satyendra Kumar, and Monojit Pal serve as directors at the Company.
- CIN/LLPIN
U74999WB2012PTC180975
- Company No.
180975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Plk Ideal Medical Systems?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Lahoti  | Director | 24-Apr-2012 | Current |
| Satyendra Kumar | Director | 24-Apr-2012 | Current |
| Monojit Pal | Director | 24-Apr-2012 | Current |
Financial Performance of Plk Ideal Medical Systems.
Plk Ideal Medical Systems Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 69.05% increase in profit. The company's net worth dipped by a decrease of 5.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plk Ideal Medical Systems?
In 2023, Plk Ideal Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Unakoti Scientific Private LimitedActive 8 years 7 days
Satyendra Kumar and Monojit Pal are mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2015 | Icici Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Plk Ideal Medical Systems?
Unlock and access historical data on people associated with Plk Ideal Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plk Ideal Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plk Ideal Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.